Important Steps to Control COVID-19/SARS-CoV-2 Infection.
Identifieur interne : 000561 ( 2020/Analysis ); précédent : 000560; suivant : 000562Important Steps to Control COVID-19/SARS-CoV-2 Infection.
Auteurs : Sudipto ChatterjeeSource :
- SN comprehensive clinical medicine [ 2523-8973 ] ; 2020.
Abstract
Elderly patients are having high mortality rates from COVID-19/SARS-CoV-2 infection compared to younger patients. The SARS-CoV-2 virus uses the ACE2 receptor as the entry point to the host cells. ARBs/ACEIs which are widely used in elderly patients, have been found to be associated with overexpression of ACE2.To decrease the severity of COVID-19 infection, ARB/ACEI should be switched to another class drug not known to cause a rise in ACE2 until the COVID-19 infection subsides. Specific human immunoglobulin can be tried for COVID-19 patients with critical conditions under supervision.
DOI: 10.1007/s42399-020-00271-7
PubMed: 32292884
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000128
- to stream PubMed, to step Curation: 000128
- to stream PubMed, to step Checkpoint: 000448
- to stream Ncbi, to step Merge: 003A63
- to stream Ncbi, to step Curation: 003A63
- to stream Ncbi, to step Checkpoint: 003A63
- to stream Main, to step Merge: 000561
- to stream Main, to step Curation: 000561
- to stream Main, to step Exploration: 000561
- to stream 2020, to step Extraction: 000561
Links to Exploration step
pubmed:32292884Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Important Steps to Control COVID-19/SARS-CoV-2 Infection.</title><author><name sortKey="Chatterjee, Sudipto" sort="Chatterjee, Sudipto" uniqKey="Chatterjee S" first="Sudipto" last="Chatterjee">Sudipto Chatterjee</name><affiliation><nlm:affiliation>Department of Pharmacology, Kempegowda Institute of Medical Science, Bangalore, Karnataka 560070 India.</nlm:affiliation><wicri:noCountry code="subField">Karnataka 560070 India</wicri:noCountry></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32292884</idno><idno type="pmid">32292884</idno><idno type="doi">10.1007/s42399-020-00271-7</idno><idno type="wicri:Area/PubMed/Corpus">000128</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000128</idno><idno type="wicri:Area/PubMed/Curation">000128</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000128</idno><idno type="wicri:Area/PubMed/Checkpoint">000448</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000448</idno><idno type="wicri:Area/Ncbi/Merge">003A63</idno><idno type="wicri:Area/Ncbi/Curation">003A63</idno><idno type="wicri:Area/Ncbi/Checkpoint">003A63</idno><idno type="wicri:Area/Main/Merge">000561</idno><idno type="wicri:Area/Main/Curation">000561</idno><idno type="wicri:Area/Main/Exploration">000561</idno><idno type="wicri:Area/2020/Extraction">000561</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Important Steps to Control COVID-19/SARS-CoV-2 Infection.</title><author><name sortKey="Chatterjee, Sudipto" sort="Chatterjee, Sudipto" uniqKey="Chatterjee S" first="Sudipto" last="Chatterjee">Sudipto Chatterjee</name><affiliation><nlm:affiliation>Department of Pharmacology, Kempegowda Institute of Medical Science, Bangalore, Karnataka 560070 India.</nlm:affiliation><wicri:noCountry code="subField">Karnataka 560070 India</wicri:noCountry></affiliation></author></analytic><series><title level="j">SN comprehensive clinical medicine</title><idno type="eISSN">2523-8973</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Elderly patients are having high mortality rates from COVID-19/SARS-CoV-2 infection compared to younger patients. The SARS-CoV-2 virus uses the ACE2 receptor as the entry point to the host cells. ARBs/ACEIs which are widely used in elderly patients, have been found to be associated with overexpression of ACE2.To decrease the severity of COVID-19 infection, ARB/ACEI should be switched to another class drug not known to cause a rise in ACE2 until the COVID-19 infection subsides. Specific human immunoglobulin can be tried for COVID-19 patients with critical conditions under supervision.</div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="Chatterjee, Sudipto" sort="Chatterjee, Sudipto" uniqKey="Chatterjee S" first="Sudipto" last="Chatterjee">Sudipto Chatterjee</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/2020/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000561 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd -nk 000561 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= 2020
|étape= Analysis
|type= RBID
|clé= pubmed:32292884
|texte= Important Steps to Control COVID-19/SARS-CoV-2 Infection.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/RBID.i -Sk "pubmed:32292884" \
| HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |